Weakness found in deadly malaria parasite

Sanger Institute researchers in Cambridge have identified the route that plasmodium falciparum--the most deadly of the malaria parasites--uses to enter red blood cells. By interrupting red blood cell receptor basigin and PfRh5, a protein on the parasite, the Sanger team was able to prevent infection. The findings, which were published in the journal Nature, could serve as a basis for a vaccine that trains the body to attack PfRh5. Report

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.